June 2016 | Volume 15 | Issue 6 | Features | 794 | Copyright © June 2016
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This
department may include additional information from the manufacturers, plus reports from physicians who wish to share their clinical experience with these new
products. In addition, we will inform our readers about the latest drugs receiving Food and Drug Administration (FDA) approval.
Dr. Perry Robins, JDD Editor-in-Chief and Mohs Surgery Pioneer, Joins Emerald Medical Applications
Emerald Medical Applications Corp., the Israeli-based company engaged in the development and sale of DermaCompare, its
proprietary artificial intelligence technology and application for the early diagnosis of melanoma and other skin cancers, announced
that Dr. Perry Robins has joined the Company's Medical Advisory Board.
Dr. Robins is Professor Emeritus of Dermatology and was Chief of the Mohs Micrographic Surgery Unit at New York University
Medical Center for over forty years. He has performed more than 47,000 Mohs surgical procedures, and trained doctors from around
the world. He is also the Founder and President of The Skin Cancer Foundation, an international organization dedicated to skin
cancer awareness, research, and public and medical education.